Volitionrx (VNRX) EPS (Basic) Growth (1y) (2013 - 2026)
Volitionrx (VNRX) EPS (Basic) Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.77 Bn | 196.16 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 126.62 Bn | 123.15 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.28 Bn | 110.06 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 74.11 Bn | 73.57 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.70 Bn | 32.75 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.80 Bn | 31.69 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.31 Bn | 22.99 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 13.85% |
| 10 | Volitionrx | 1.17 Mn | -1.63 Mn | - | -16.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.58% |
| Dec 31, 2025 | 104.50% |
| Sep 30, 2025 | 99.46% |
| Jun 30, 2025 | 100.40% |
| Mar 31, 2025 | 33.84% |
| Dec 31, 2024 | 46.02% |
| Sep 30, 2024 | 38.13% |
| Jun 30, 2024 | 40.33% |
| Mar 31, 2024 | 30.02% |
| Dec 31, 2023 | 6.68% |
| Sep 30, 2023 | 22.40% |
| Jun 30, 2023 | -9,358.21% |
| Mar 31, 2023 | -9,442.49% |
| Dec 31, 2022 | 14.26% |
| Sep 30, 2022 | -2.79% |
| Jun 30, 2022 | 70.35% |
| Mar 31, 2022 | 743.93% |
| Dec 31, 2021 | -29,151.94% |
| Sep 30, 2021 | -78,513.78% |
| Jun 30, 2021 | 574.51% |